X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1026) 1026
Publication (130) 130
Book Chapter (11) 11
Book Review (7) 7
Government Document (5) 5
Conference Proceeding (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (793) 793
female (561) 561
oncology (516) 516
index medicus (491) 491
sporadic breast (363) 363
breast neoplasms - genetics (314) 314
breast cancer (302) 302
cancer (273) 273
middle aged (263) 263
brca1 (250) 250
genetic aspects (241) 241
mutation (239) 239
adult (238) 238
aged (214) 214
ovarian-cancer (206) 206
dna methylation (196) 196
expression (167) 167
male (159) 159
methylation (157) 157
tumors (154) 154
sporadic breast-cancer (147) 147
brca1 protein - genetics (146) 146
research (141) 141
breast neoplasms - pathology (140) 140
genes (140) 140
genetics & heredity (136) 136
genes, brca1 (131) 131
animals (129) 129
mutations (123) 123
biochemistry & molecular biology (119) 119
cell biology (117) 117
prognosis (116) 116
breast-cancer (113) 113
promoter regions, genetic (112) 112
risk factors (112) 112
gene (111) 111
genetic predisposition to disease (107) 107
aged, 80 and over (106) 106
gene expression regulation, neoplastic (101) 101
analysis (100) 100
gene expression (100) 100
pathology (100) 100
skin and connective tissue diseases (91) 91
ovarian neoplasms - genetics (90) 90
loss of heterozygosity (88) 88
ovarian cancer (88) 88
risk (86) 86
cell line, tumor (84) 84
breast neoplasms - metabolism (81) 81
health aspects (79) 79
immunohistochemistry (78) 78
polymerase chain reaction (78) 78
sporadic breast cancer (78) 78
proteins (77) 77
dna repair (73) 73
carcinoma (72) 72
article (71) 71
brca2 (71) 71
microsatellite instability (71) 71
brca1 protein - metabolism (70) 70
carcinomas (69) 69
gene mutations (69) 69
medicine & public health (68) 68
case-control studies (67) 67
neoplasm proteins - genetics (67) 67
dna (65) 65
genetics (64) 64
base sequence (63) 63
care and treatment (63) 63
development and progression (63) 63
gene-expression (63) 63
genes, brca2 (63) 63
endocrine system diseases (61) 61
promoter hypermethylation (60) 60
hypermethylation (59) 59
messenger-rna (59) 59
mice (59) 59
genetic research (57) 57
research article (56) 56
germline mutations (55) 55
biomarkers, tumor - genetics (54) 54
cells (54) 54
tumor-suppressor gene (54) 54
promoter regions, genetic - genetics (53) 53
neoplasms - genetics (52) 52
germ-line mutation (51) 51
medicine (51) 51
phenotype (51) 51
association (50) 50
brca2 protein - genetics (50) 50
deoxyribonucleic acid--dna (50) 50
genotype (50) 50
dna, neoplasm - genetics (49) 49
sporadic (49) 49
susceptibility (49) 49
chemotherapy (48) 48
epigenetics (48) 48
neoplasm staging (46) 46
poly polymerase (46) 46
somatic mutations (46) 46
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1032) 1032
French (4) 4
German (1) 1
Korean (1) 1
Persian (1) 1
Polish (1) 1
Slovak (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
PLoS ONE, ISSN 1932-6203, 11/2016, Volume 11, Issue 11, p. e0165436
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2011, Volume 364, Issue 3, pp. 205 - 214
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2013, Volume 8, Issue 2, p. e56256
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 11/2007, Volume 99, Issue 22, pp. 1683 - 1694
Journal Article
Journal of Cancer Research and Clinical Oncology, ISSN 0171-5216, 02/2011, Volume 137, Issue 2, pp. 183 - 192
Triple-negative breast cancers (TNBC) neither express hormone receptors, nor overexpress HER2. They are associated with poor prognosis, as defined by low... 
Medicine & Public Health | Hematology | Basal-like breast cancer (BBC) | Patient outcome | Adjuvant treatment | Internal Medicine | Cancer Research | Oncology | Triple-negative breast cancer (TNBC) | BRCA1 | POLY(ADP-RIBOSE) POLYMERASE | MUTATION CARRIERS | GENE-EXPRESSION PROFILES | SPORADIC BREAST | PROGNOSTIC VALUE | INVASIVE DUCTAL CARCINOMA | GROWTH-FACTOR RECEPTOR | NEOADJUVANT CHEMOTHERAPY | ONCOLOGY | BASAL-LIKE PHENOTYPE | CLINICAL-IMPLICATIONS | Genomic Instability | Receptors, Estrogen - metabolism | Prognosis | Humans | Gene Expression Regulation, Neoplastic | Receptor, ErbB-2 - metabolism | Breast Neoplasms - metabolism | Receptors, Progesterone - metabolism | Anthracyclines - administration & dosage | Biomarkers, Tumor - metabolism | Female | Genes, BRCA1 | Molecular Targeted Therapy - methods | Treatment Outcome | Clinical Trials as Topic | Breast Neoplasms - drug therapy | Poly(ADP-ribose) Polymerase Inhibitors | Taxoids - administration & dosage | Breast Neoplasms - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Neoadjuvant Therapy - methods | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Breast Neoplasms - mortality | Mutation | Poly (ADP-Ribose) Polymerase-1 | Anthracyclines | Online health care information services | Developmental biology | Oncology, Experimental | Breast cancer | Research | Cancer | Review
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 12/2008, Volume 14, Issue 24, pp. 8010 - 8018
Journal Article
Oncology Reports, ISSN 1021-335X, 9/2013, Volume 30, Issue 3, pp. 1019 - 1029
Journal Article